NeoPharm/FDA IL-13 Soon To Enter Clinic; Elengold Details CBER Research
Executive Summary
FDA's first major research collaboration with regulated industry will enter Phase I clinical trials in the near future, FDA's Center for Biologics Evaluation & Research Deputy Director for Operations Mark Elengold told the PDA/FDA joint conference Sept. 29.